Capsule summary of NCCN Guidelines for Hodgkin Lymphoma

Long Term Outcomes of Relapsed/Refractory Non-Hodgkin Lymphoma:
A Single Center Experience

Liposomal Doxorubicin based Chemotherapy in the treatment of Relapsed Diffuse Large B-cell Lymphoma

Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma

Treatment of relapsed classical Hodgkin lymphoma in the Brentuximab vedoitn era.

Clinicopathological Significance of A20 Genetic Mutation in Diffuse Large B-Cell Lymphoma

Bone marrow infiltration in diffuse large B-cell lymphoma: impact of 18FDG-PET/CT in detection and prediction of therapy outcome

RETROSPECTIVE ANALYSIS OF CLINICO-EPIDEMIOLOGICAL FEATURES AND OUTCOMES OF DIFFUSE LARGE B CELL LYMPHOMA IN ADULT PATIENTS TREATED AT CLINICAL ONCOLOGY DEPARTMENT, AIN SHAMS UNIV

Peripheral T-cell Lymphomas

The Clinical Characteristics and Treatment Response of Patients with Low Grade Non-Hodgkin Lymphoma